Veterinary Medicines

EPILEPTYL

Authorised
  • Cresol C5
  • Calcium arsenicosum C15
  • CUPRUM METALLICUM C9
  • BUFO RANA C12
  • Oenanthe crocata C9
  • Coriaria myrtifolia C12
  • Veratrum viride C5
  • Cicuta virosa C15
  • Cresol C9
  • Cresol C7
Download as PDF

Product identification

Medicine name:
EPILEPTYL
Active substance:
  • Cresol C5
  • Calcium arsenicosum C15
  • CUPRUM METALLICUM C9
  • BUFO RANA C12
  • Oenanthe crocata C9
  • Coriaria myrtifolia C12
  • Veratrum viride C5
  • Cicuta virosa C15
  • Cresol C9
  • Cresol C7
Target species:
  • Cat
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cresol C5
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Calcium arsenicosum C15
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • CUPRUM METALLICUM C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • BUFO RANA C12
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Oenanthe crocata C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Coriaria myrtifolia C12
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Veratrum viride C5
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cicuta virosa C15
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cresol C9
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
  • Cresol C7
    0.10
    gram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Oral solution
Withdrawal period by route of administration:
  • Oral use
    • Cat
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QV03AX
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription except for some pack sizes
Authorisation status:
  • Valid
Authorised in:
  • France
Available in:
  • France
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis not covered by Directive 2001/82/EC
Marketing authorisation holder:
  • Boiron
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boiron
Responsible authority:
  • National Veterinary Medicines Agency
Authorisation number:
  • FR/V/4516876 7/2008
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
French (PDF)
Published on: 4/04/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."